Franklin Resources
MED icon

Franklin Resources’s Medifast MED Stock Holding History

Franklin Resources’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,140
Closed -$350K – 2931
2024
Q1 		$350K Buy
9,140
+2,472
+37% +$120K ﹤0.01% 2409
2023
Q4 		$448K Buy
6,668
+407
+7% +$28.4K ﹤0.01% 2002
2023
Q3 		$469K Buy
6,261
+243
+4% +$21.6K ﹤0.01% 1947
2023
Q2 		$555K Buy
+6,018
New +$536K ﹤0.01% 1920
2022
Q4 		– Sell
-4,184
Closed -$453K – 2363
2022
Q3 		$453K Buy
4,184
+120
+3% +$17.2K ﹤0.01% 1716
2022
Q2 		$734K Sell
4,064
-2,791
-41% -$499K ﹤0.01% 1608
2022
Q1 		$1.17M Sell
6,855
-373
-5% -$70.3K ﹤0.01% 1571
2021
Q4 		$1.51M Buy
7,228
+998
+16% +$206K ﹤0.01% 1562
2021
Q3 		$1.2M Buy
+6,230
New +$1.53M ﹤0.01% 1580
2020
Q1 		– Sell
-2,530
Closed -$277K – 1531
2019
Q4 		$277K Buy
+2,530
New +$245K ﹤0.01% 1436

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Franklin Resources's MED Position: Q2 2024 in Review

Franklin Resources sold out of Medifast (MED) in Q2 2024, closing a stake of 9,140 shares — an estimated $350K sold.

Franklin Resources first reported a position in MED in Q4 2019 and held it in 10 quarters. The position peaked at $1.51M in Q4 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Franklin Resources reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Franklin Resources sold 9,140 Medifast shares in Q2 2024, an estimated $350K.
  • Franklin Resources first reported a position in Medifast in Q4 2019 and held it in 10 quarters.
  • Franklin Resources's Medifast position peaked at $1.51M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Franklin Resources's 13F filing for Q2 2024, filed 14 Aug 2024.